tiprankstipranks
Statera BioPharma (STAB)
OTHER OTC:STAB
US Market
Holding STAB?
Track your performance easily

Statera BioPharma (STAB) Income Statement

190 Followers

Statera BioPharma Income Statement

Last quarter (Q3 2022), Statera BioPharma's total revenue was $670.50K, an increase of 183.49% from the same quarter last year. In Q3, Statera BioPharma's net income was $-3.35M. See Statera BioPharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19
Total Revenue
$ 3.69M$ 1.49M$ 262.94K$ 1.11M
Cost of Revenue
$ 895.41K$ 488.31K--
Gross Profit
$ 355.11K$ -488.31K$ 262.94K$ 1.11M
Operating Expense
$ 81.02M$ 99.34M$ 10.50M$ 3.47M
Operating Income
$ -95.34M$ -98.34M$ -10.50M$ -2.36M
Net Non Operating Interest Income Expense
----
Other Income Expense
$ 745.59K$ 3.53M$ 1.59M$ 332.50K
Pretax Income
$ -99.04M$ -101.88M$ -12.09M$ -2.69M
Tax Provision
----
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -102.53M$ -101.85M$ -12.09M$ -2.65M
Basic EPS
$ -1.39$ -2.90$ -0.19-
Diluted EPS
$ -1.39$ -2.90$ -0.19$ -0.28
Basic Average Shares
$ 172.20M$ 35.11M$ 12.40M$ 11.30M
Diluted Average Shares
$ 172.20M$ 35.11M$ 12.40M$ 11.30M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 98.56M$ 99.83M$ 10.50M$ 3.47M
Net Income From Continuing And Discontinued Operation
$ -102.53M$ -101.85M$ -12.09M$ -2.65M
Normalized Income
$ -10.62M$ -12.88M--
Interest Expense
----
EBIT
$ -99.05M$ -29.32M$ -10.91M$ -2.69M
EBITDA
$ -98.61M$ -29.06M$ -10.91M$ -2.68M
Currency in USD

Statera BioPharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis